SoftBank Investment Advisers

ElevateBio, LLC is a holding company based in Cambridge, Massachusetts, focused on the development of cell and gene-based therapies for treating cancer and viral infections. Founded in 2017 by Vikas Sinha, Mitchell Finer, and David Hallal, ElevateBio operates a portfolio of companies dedicated to creating life-changing medicines. The company collaborates with leading scientists and innovators to build this portfolio and has established a centralized facility that streamlines the transition from research and development to the commercialization of these therapies. This integrated approach enhances efficiency and accelerates the availability of medical products aimed at addressing severe diseases.

Cybereason Inc. is a cybersecurity company specializing in endpoint protection through its advanced platform that offers endpoint detection and response, next-generation antivirus, and anti-ransomware solutions. Founded in 2012 and headquartered in Boston, Massachusetts, with additional offices in London, Tel Aviv, and Tokyo, Cybereason's platform utilizes a custom-built in-memory graph to automate the detection of behavioral patterns across endpoints. This technology allows organizations to identify and respond to cyber threats effectively by revealing the full scope of an attack and enabling rapid response actions. The company's product offerings include solutions for behavioral data analysis, advanced attack prevention, and threat investigation, alongside managed monitoring and incident response services. Cybereason's focus is on providing enterprises with the tools needed to outmaneuver cyber adversaries.

Vendr, Inc. is a Boston-based company that specializes in a software-as-a-service (SaaS) platform designed to streamline the purchasing and renewal of software for businesses. Founded in 2018, Vendr offers a comprehensive suite of services, including commercial negotiations, renewal management, and contract logistics. By leveraging a vast dataset from numerous transactions, Vendr empowers finance and procurement teams to make informed decisions, find suitable software solutions, and negotiate fair prices. The platform facilitates the entire purchasing process, from discovering new tools to managing upcoming renewals, thereby helping clients to minimize software expenses. Recently, Vendr raised significant funding and expanded its capabilities through the acquisition of Blissfully, a SaaS management platform.

Proximie Inc. is a health technology company based in Bedford, Massachusetts, that specializes in a telehealth platform designed for virtual surgical assistance. Founded in 2016 by Nadine Hachach-Haram, Proximie's platform enables surgeons to remotely observe and guide complex surgical procedures using augmented reality, artificial intelligence, and machine learning. This technology allows expert surgeons to connect with their peers globally, sharing knowledge and skills in real-time, regardless of their physical location. The platform is adaptable, compatible with various devices and software used in operating rooms, and can function effectively even in low bandwidth environments. Proximie aims to enhance surgical practices by democratizing access to expert guidance and fostering collaboration among medical professionals.

Cornami, Inc. is a high-performance computing company based in Campbell, California, with additional offices in Sacramento and Boston. Founded in 2011, Cornami has developed a patented multi-core technology that enhances software performance, power efficiency, and latency while significantly increasing compute performance. This innovative approach allows processor cores to function as scalable resources, similar to memory and storage, facilitating real-time computing with minimal cost and power consumption. Cornami's technology aims to support a variety of markets, with an initial emphasis on Big Data, by enabling real-time fully homomorphic encryption and providing high-performance computing capabilities across diverse devices and platforms.

RightHand Robotics, Inc. specializes in the manufacturing of robotic order-picking systems designed to enhance supply chain logistics and order fulfillment across various industries, including e-commerce, food handling, and flexible manufacturing. Founded in 2015, the company is headquartered in Cambridge, Massachusetts, with an additional office in Frankfurt, Germany. RightHand Robotics offers innovative solutions like the ReFlex SF, which features a 3D-printed palm equipped with advanced servos and compliant fingers, and the ReFlex TakkTile, a tactile sensor that aids in gentle object handling. Their technology enables robots to automatically grasp a wide range of items from bins and cases without the need for extensive data entry or parameter tuning, making their systems cost-effective and adaptable to changing business needs.

Dewpoint Therapeutics is a Boston-based biotech company focused on the research and development of treatments targeting biomolecular condensates to address various diseases, including cancer, neurodegenerative disorders, and immunological conditions. Founded in 2018, the company employs an innovative drug platform that utilizes machine-learning-based image analysis for visualizing condensates. This technology supports an engine of engineered cell lines designed to track and mitigate harmful protein sequestration. By leveraging its proprietary platform, Dewpoint seeks to facilitate drug discovery across a wide range of medical indications and collaborates with leading academic and pharmaceutical partners to enhance the accessibility of new therapies for unmet healthcare needs.

ezCater, Inc. is an online catering marketplace that facilitates food ordering for both small startups and large corporations. Founded in 2007 and headquartered in Boston, Massachusetts, with an additional office in Denver, the company connects businesses with local caterers and restaurants across the nation. ezCater offers a platform that allows users to easily find and order food for meetings and events, utilizing features that filter caterers by food type, budget, and other criteria. The company's solutions include ezManage, a catering management platform, and ezOrdering, which enables restaurants to accept catering orders directly through their websites. By streamlining the catering process, ezCater helps clients save time and efficiently select suitable catering options.

Pear Therapeutics, Inc. is a healthcare company specializing in the discovery, development, and delivery of software-based therapeutics aimed at treating behavioral health disorders, including addiction, schizophrenia, anxiety, depression, and chronic insomnia. Founded in 2013 and headquartered in Boston, with an additional office in San Francisco, Pear Therapeutics offers a range of digital therapies designed to enhance treatment outcomes. Notable products include reSET, a tool for substance abuse treatment used alongside traditional therapy; reSET-O, which addresses opioid use disorder; and Somryst, aimed at chronic insomnia. The company also provides PearConnect, a patient services center that connects users with advocates, clinicians, and insurance providers to facilitate support and resource access throughout treatment. By integrating digital interventions with pharmaceuticals, Pear Therapeutics aims to improve patient engagement, clinical outcomes, and cost-effectiveness in healthcare.

Gelato operates an on-demand printing platform that specializes in customized print products. It enables entrepreneurs, creators, and global brands to sell their products worldwide while producing them locally in 30 countries, thus streamlining the logistics and eliminating the need for inventory management or cross-border shipping. This approach allows businesses of all sizes to efficiently scale their e-commerce operations, reaching a vast consumer base of up to 5 billion people. Gelato's commitment to sustainability and efficiency positions it as a leader in the customized print market. The company has a global presence with offices in key cities, including Boston, London, and Tokyo, while headquartered in Oslo, Norway.

Cybereason Inc. is a cybersecurity company specializing in endpoint protection through its advanced platform that offers endpoint detection and response, next-generation antivirus, and anti-ransomware solutions. Founded in 2012 and headquartered in Boston, Massachusetts, with additional offices in London, Tel Aviv, and Tokyo, Cybereason's platform utilizes a custom-built in-memory graph to automate the detection of behavioral patterns across endpoints. This technology allows organizations to identify and respond to cyber threats effectively by revealing the full scope of an attack and enabling rapid response actions. The company's product offerings include solutions for behavioral data analysis, advanced attack prevention, and threat investigation, alongside managed monitoring and incident response services. Cybereason's focus is on providing enterprises with the tools needed to outmaneuver cyber adversaries.

Perch is a technology-driven commerce company based in Boston, Massachusetts, that specializes in acquiring and operating successful Amazon FBA businesses. The firm focuses on products with a strong history of customer satisfaction and aims to maintain a presence among the top three products in their respective categories on Amazon. Its portfolio includes a diverse range of brands, such as those producing exfoliating brushes, slime-making kits, leggings, and reusable straws. To optimize its operations, Perch employs a platform for sales analytics, pricing strategies, advertising, marketing, and inventory management. Founded in 2019, Perch has positioned itself as a key player in the e-commerce landscape by leveraging technology to enhance its business processes.

Formlabs Inc. is a company that designs and manufactures advanced 3D printing systems targeted at engineers, designers, and artists. Established in 2011 and headquartered in Somerville, Massachusetts, Formlabs offers a diverse range of products, including the Form 3, Form 3B, and Form 3L printers, all utilizing Low Force Stereolithography (LFS) technology. The company also provides post-processing solutions such as Form Wash and Form Cure, as well as the Fuse 1 SLS 3D printer and the Form Cell manufacturing solution. Formlabs develops high-performance materials for various applications in industries like dental, healthcare, jewelry, and education. Its PreForm software facilitates the preparation of models for printing, making it a preferred choice among professionals worldwide. With additional offices in Germany, Japan, China, Singapore, Hungary, and North Carolina, Formlabs continues to innovate in the field of 3D printing, enhancing the capabilities of digital fabrication.

Repertoire Immune Medicines is a clinical-stage biotechnology company founded in 2016 and based in Cambridge, Massachusetts. The company focuses on harnessing the power of T cells to develop innovative therapies aimed at preventing, treating, and curing cancer, autoimmune conditions, and infectious diseases. Repertoire Immune Medicines is actively engaged in experimental clinical trials that utilize autologous T cells primed against specific cancer antigens and linked to IL-15. Additionally, the company specializes in the characterization of T cell receptor (TCR)-antigen pairs, allowing for the rational design and development of targeted immune medicines. These efforts are designed to enhance the human immune system's capabilities, providing new treatment options for patients with serious health challenges.

ElevateBio, LLC is a holding company based in Cambridge, Massachusetts, focused on the development of cell and gene-based therapies for treating cancer and viral infections. Founded in 2017 by Vikas Sinha, Mitchell Finer, and David Hallal, ElevateBio operates a portfolio of companies dedicated to creating life-changing medicines. The company collaborates with leading scientists and innovators to build this portfolio and has established a centralized facility that streamlines the transition from research and development to the commercialization of these therapies. This integrated approach enhances efficiency and accelerates the availability of medical products aimed at addressing severe diseases.

Pear Therapeutics, Inc. is a healthcare company specializing in the discovery, development, and delivery of software-based therapeutics aimed at treating behavioral health disorders, including addiction, schizophrenia, anxiety, depression, and chronic insomnia. Founded in 2013 and headquartered in Boston, with an additional office in San Francisco, Pear Therapeutics offers a range of digital therapies designed to enhance treatment outcomes. Notable products include reSET, a tool for substance abuse treatment used alongside traditional therapy; reSET-O, which addresses opioid use disorder; and Somryst, aimed at chronic insomnia. The company also provides PearConnect, a patient services center that connects users with advocates, clinicians, and insurance providers to facilitate support and resource access throughout treatment. By integrating digital interventions with pharmaceuticals, Pear Therapeutics aims to improve patient engagement, clinical outcomes, and cost-effectiveness in healthcare.

XtalPi Inc. is a pharmaceutical technology company based in Cambridge, Massachusetts, with additional offices in China. Founded in 2014 by a team of quantum physicists from MIT, XtalPi focuses on transforming drug research and development through its Intelligent Digital Drug Discovery and Development (ID4) platform. This platform integrates quantum mechanics, artificial intelligence, and high-performance cloud computing to enhance the efficiency and accuracy of drug R&D processes. XtalPi's offerings include advanced tools for crystal structure prediction and determination, solid state testing, small molecule drug design, and AI model development. The company aims to accelerate drug discovery and development, thereby contributing to global health improvements. Its innovative technologies have garnered recognition within the industry and facilitated strategic partnerships with leading pharmaceutical companies.

Zymergen, Inc. is a biotechnology company based in Emeryville, California, established in 2013, with additional offices in Boise, Idaho; Medford, Massachusetts; Seattle, Washington; and Tokyo, Japan. The company focuses on researching, developing, and manufacturing microbes for a variety of sectors, including agriculture, chemicals, materials, pharmaceuticals, electronics, and personal care. Zymergen employs a platform that integrates automation, machine learning, and genomics to enhance the optimization of microbial strains, improve existing production processes, and bridge the gap between lab and commercial manufacturing. Additionally, the company offers services for new product development, leveraging its expertise to engineer novel molecules from microbes, thereby harnessing the potential of biological innovation to create advanced materials and products across multiple industries.

Biofourmis is a biotechnology company based in Boston, Massachusetts, founded in 2015. It specializes in personalized care and therapies through the use of digital therapeutics. The company develops and delivers clinically validated software-based therapeutics that enhance patient outcomes. Biofourmis has created a predictive health analytics platform that analyzes physiology data gathered from clinical-grade wearables. Utilizing artificial intelligence, this platform integrates and interprets continuous physiological data to identify personalized patterns and predict potential clinical exacerbations. By enabling medical professionals to intervene days before critical events occur, Biofourmis aims to improve patient care and provide cost-effective solutions for healthcare providers.

Automation Anywhere, Inc. is a global leader in Robotic Process Automation (RPA), specializing in AI-powered software solutions that automate repetitive business tasks. The company's cloud-native platform integrates RPA with artificial intelligence, machine learning, and analytics to improve productivity, customer experience, and employee engagement. Key offerings include Automation Anywhere Enterprise, which automates IT and business processes; Automation Anywhere Server; and the Premier application for creating and managing automation visually. The company also provides solutions like Process inVision for documenting processes and various Testing Anywhere products for quality assurance across multiple platforms. Additionally, Automation Anywhere offers consulting services and has established a strategic partnership with Microsoft Azure. Founded in 2003 and headquartered in San Jose, California, the company operates offices in major global cities, including Boston, Dallas, New York, and various locations in Asia and Europe.

Cybereason Inc. is a cybersecurity company specializing in endpoint protection through its advanced platform that offers endpoint detection and response, next-generation antivirus, and anti-ransomware solutions. Founded in 2012 and headquartered in Boston, Massachusetts, with additional offices in London, Tel Aviv, and Tokyo, Cybereason's platform utilizes a custom-built in-memory graph to automate the detection of behavioral patterns across endpoints. This technology allows organizations to identify and respond to cyber threats effectively by revealing the full scope of an attack and enabling rapid response actions. The company's product offerings include solutions for behavioral data analysis, advanced attack prevention, and threat investigation, alongside managed monitoring and incident response services. Cybereason's focus is on providing enterprises with the tools needed to outmaneuver cyber adversaries.

Boston Dynamics, Inc. is an engineering company based in Waltham, Massachusetts, specializing in the design and manufacture of advanced robots and software for human simulation. Founded in 1992 as a spin-off from the Massachusetts Institute of Technology, the company has gained recognition for its innovative robots that mimic animal movement, such as Spot, a quadruped robot, and Atlas, a humanoid robot. These robots are equipped with cutting-edge mobility, dexterity, and intelligence, allowing them to perform tasks in challenging environments, including industrial plants, construction sites, and warehouses. Boston Dynamics also develops software for human simulation, which is utilized in various training applications, including law enforcement and military operations. The company collaborates with organizations globally, providing solutions to some of the most complex challenges in automation and robotics.

Relay Therapeutics is a clinical-stage precision medicine company based in Cambridge, Massachusetts, focused on transforming the drug discovery process, particularly in targeted oncology. Utilizing its innovative Dynamo platform, the company combines advanced computational techniques with experimental methods to enhance small molecule therapeutic discovery. Relay Therapeutics is developing several product candidates, including RLY-1971, an oral inhibitor targeting the SHP2 protein, currently in Phase 1 trials for advanced solid tumors; RLY-4008, a selective inhibitor for patients with FGFR2 alterations; and RLY-PI3K1047, aimed at cancer-associated mutations of the PI3K alpha protein. Founded in 2015, Relay Therapeutics is dedicated to addressing complex diseases through its unique approach to drug discovery.

Zymergen, Inc. is a biotechnology company based in Emeryville, California, established in 2013, with additional offices in Boise, Idaho; Medford, Massachusetts; Seattle, Washington; and Tokyo, Japan. The company focuses on researching, developing, and manufacturing microbes for a variety of sectors, including agriculture, chemicals, materials, pharmaceuticals, electronics, and personal care. Zymergen employs a platform that integrates automation, machine learning, and genomics to enhance the optimization of microbial strains, improve existing production processes, and bridge the gap between lab and commercial manufacturing. Additionally, the company offers services for new product development, leveraging its expertise to engineer novel molecules from microbes, thereby harnessing the potential of biological innovation to create advanced materials and products across multiple industries.

Automation Anywhere, Inc. is a global leader in Robotic Process Automation (RPA), specializing in AI-powered software solutions that automate repetitive business tasks. The company's cloud-native platform integrates RPA with artificial intelligence, machine learning, and analytics to improve productivity, customer experience, and employee engagement. Key offerings include Automation Anywhere Enterprise, which automates IT and business processes; Automation Anywhere Server; and the Premier application for creating and managing automation visually. The company also provides solutions like Process inVision for documenting processes and various Testing Anywhere products for quality assurance across multiple platforms. Additionally, Automation Anywhere offers consulting services and has established a strategic partnership with Microsoft Azure. Founded in 2003 and headquartered in San Jose, California, the company operates offices in major global cities, including Boston, Dallas, New York, and various locations in Asia and Europe.

Findability Sciences specializes in leveraging big data, cognitive computing, and artificial intelligence through its flagship product, the Findability Platform®. This award-winning platform enhances data context and features self-learning capabilities, providing tailored solutions for global corporations across various sectors, including insurance, retail, manufacturing, financial services, healthcare, and transportation. By unifying structured and unstructured data, the platform maximizes data asset value and facilitates conversational computing via chatbots and virtual agents. It generates actionable insights that enable marketing professionals to understand consumer personas and predict trends related to costs, pricing, and risks more accurately than ever before. Headquartered near Boston, MA, Findability Sciences operates in the United States, Japan, and India, and collaborates with major technology providers, including being part of the IBM Watson Partner Ecosystem. The company is also invested in a joint venture with SoftBank and a privately held predictive modeling technology firm.

Cybereason Inc. is a cybersecurity company specializing in endpoint protection through its advanced platform that offers endpoint detection and response, next-generation antivirus, and anti-ransomware solutions. Founded in 2012 and headquartered in Boston, Massachusetts, with additional offices in London, Tel Aviv, and Tokyo, Cybereason's platform utilizes a custom-built in-memory graph to automate the detection of behavioral patterns across endpoints. This technology allows organizations to identify and respond to cyber threats effectively by revealing the full scope of an attack and enabling rapid response actions. The company's product offerings include solutions for behavioral data analysis, advanced attack prevention, and threat investigation, alongside managed monitoring and incident response services. Cybereason's focus is on providing enterprises with the tools needed to outmaneuver cyber adversaries.

Boston Dynamics, Inc. is an engineering company based in Waltham, Massachusetts, specializing in the design and manufacture of advanced robots and software for human simulation. Founded in 1992 as a spin-off from the Massachusetts Institute of Technology, the company has gained recognition for its innovative robots that mimic animal movement, such as Spot, a quadruped robot, and Atlas, a humanoid robot. These robots are equipped with cutting-edge mobility, dexterity, and intelligence, allowing them to perform tasks in challenging environments, including industrial plants, construction sites, and warehouses. Boston Dynamics also develops software for human simulation, which is utilized in various training applications, including law enforcement and military operations. The company collaborates with organizations globally, providing solutions to some of the most complex challenges in automation and robotics.

Zymergen, Inc. is a biotechnology company based in Emeryville, California, established in 2013, with additional offices in Boise, Idaho; Medford, Massachusetts; Seattle, Washington; and Tokyo, Japan. The company focuses on researching, developing, and manufacturing microbes for a variety of sectors, including agriculture, chemicals, materials, pharmaceuticals, electronics, and personal care. Zymergen employs a platform that integrates automation, machine learning, and genomics to enhance the optimization of microbial strains, improve existing production processes, and bridge the gap between lab and commercial manufacturing. Additionally, the company offers services for new product development, leveraging its expertise to engineer novel molecules from microbes, thereby harnessing the potential of biological innovation to create advanced materials and products across multiple industries.

The Company has collaborated with M.D. Anderson Cancer Center in Houston, Texas; Massachusetts Institute of Technology in Cambridge, Massachusetts; and Rhode Island Hospital/Brown University in Providence, Rhode Island where teams of researchers are continuing advances on the Company's core technologies.